Other: Exercise intervention ( DrugBank: - )

---

2 diseases

ID	Disease name (Link within this page)	Number of trials
13	Multiple sclerosis/Neuromyelitis optica	1
18	Spinocerebellar degeneration	1

13. Multiple sclerosis/Neuromyelitis optica

---

Clinical trials : 3,342 /  Drugs : 2,355 - (DrugBank : 406) / Drug target genes : 269 - Drug target pathways : 241

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03418376 (ClinicalTrials.gov)	February 1, 2017	9/1/2018	Carnosine Loading and Periodized Training in MS and HC	The Impact of Carnosine Loading and Rehabilitation Therapy on Exercise Capacity in Multiple Sclerosis.	Multiple Sclerosis;Exercise Therapy;Dietary Supplement	Dietary Supplement: Beta-alanine supplementation;Other: Exercise intervention	Hasselt University	NULL	Completed	18 Years	75 Years	All	45	N/A	Belgium

18. Spinocerebellar degeneration

---

Clinical trials : 71 /  Drugs : 99 - (DrugBank : 30) / Drug target genes : 45 - Drug target pathways : 65

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04192136 (ClinicalTrials.gov)	September 3, 2020	6/12/2019	NAD+ and Exercise in FA	NAD+ Precursor Supplementation With Exercise Training to Increase Aerobic Capacity in Friedreich's Ataxia	Friedreich Ataxia 1	Dietary Supplement: Nicotinamide Riboside;Dietary Supplement: Placebo;Other: Exercise Intervention	Children's Hospital of Philadelphia	National Institutes of Health (NIH)	Recruiting	10 Years	40 Years	All	72	N/A	United States